Skip to main content

Saturn Medic

Question Bank

COPD Pharmacology — Respiratory & Allergy Pharmacology

Pharmacology Question Bank

Free preview — 5 of 30 COPD Pharmacology questions. Create a free student account to unlock all 30 questions in this topic.
Create free account
Pharmacology Question Bank
COPD Pharmacology
Respiratory & Allergy Pharmacology · COPD Pharmacology · medium
Question 1 of 5
20% complete
0 s
Q1
Accuracy
No answers yet
Quick Tip
Question Navigator
Current
Correct
Incorrect
Unanswered

COPD Pharmacology MCQs: practice questions

Sample COPD Pharmacology multiple-choice questions from Respiratory & Allergy Pharmacology.

  1. Which mucolytic can modestly reduce COPD exacerbation rates?

    • A. Guaifenesin
    • B. Dextromethorphan
    • C. Codeine
    • D. Albuterol
    • E. N-Acetylcysteine
  2. Which bronchodilator class decreases vagally mediated bronchoconstriction?

    • A. Leukotriene antagonists
    • B. Muscarinic antagonists
    • C. Mast-cell stabilizers
    • D. H1 antagonists
    • E. PDE4 inhibitors
  3. Which PDE4 inhibitor is approved for COPD and reduces exacerbations?

    • A. Theophylline
    • B. Roflumilast
    • C. Cromolyn
    • D. Salmeterol
    • E. Ipratropium
  4. Which statement about inhaled glucocorticoids in COPD is most consistent with the supplied text?

    • A. They are poorly effective and are not recommended in early-stage COPD
    • B. They are first-line mucolytics
    • C. They are the only effective maintenance therapy
    • D. They rapidly reverse acute bronchospasm
    • E. They directly inhibit acetylcholine receptors
  5. Which COPD therapy is most directly associated with PDE4 inhibition?

    • A. Tiotropium
    • B. Ipratropium
    • C. Roflumilast
    • D. Albuterol
    • E. N-acetylcysteine
  6. Which adverse effect can limit the use of atropine as an antiasthmatic?

  7. Which COPD drug acts through PDE4 rather than through a bronchial receptor?

  8. Which drug used in COPD is a mucolytic rather than a bronchodilator?

  9. Which treatment can be added to tiotropium in COPD when recurrent serious exacerbations persist?

  10. Which inhaled anticholinergic is used in COPD and has low systemic absorption?

  11. Which drug is administered as an inhalant and acts by decreasing mucus viscosity?

  12. Which drug class reduces mucus secretion by decreasing vagal stimulation?

  13. Which drug is a long-acting antimuscarinic rather than a β2 agonist?

  14. Which adverse effect is most likely after excessive β2-agonist use?

  15. Which drug is more likely to produce systemic anticholinergic effects because it is readily absorbed?

  16. Which bronchodilator blocks acetylcholine at muscarinic receptors?

  17. Which class is poorly effective in COPD compared with asthma according to the supplied text?

  18. Which long-acting muscarinic antagonist is approved for maintenance treatment of COPD?

  19. Which treatment is directed at COPD exacerbation reduction rather than immediate bronchodilation?

  20. Which drug is a long-acting β2 agonist useful as controller therapy in obstructive airway disease?

  21. Which short-acting β2 agonist has an inhaled onset of about 1–5 minutes?

  22. Which agent is least likely to be useful for routine COPD treatment?

  23. Which drug should not be selected as routine early-stage COPD therapy according to the discussion?

  24. Which mucolytic reduces mucus viscosity by cleaving disulfide bonds?

  25. Which COPD drug is administered orally rather than by inhalation?

  26. Which drug is most directly useful for a patient with α1-proteinase inhibitor deficiency causing emphysema?

  27. Which drug is ineffective for COPD according to the question explanation?

  28. Which inhaled anticholinergic is a quaternary amine?

  29. Which COPD drug can cause nausea, weight loss, and mental health problems?

  30. A patient with COPD remains symptomatic despite inhaled tiotropium and has recurrent exacerbations. Which additional drug is specifically supported by the question set?

SaturnMedic